Review Article

Effects of Systemic or Local Administration of Zoledronate on Implant Osseointegration: A Preclinical Meta-Analysis

Table 1

Characteristics of enrolled studies.

StudiesAnimalsGroupZOL dosage and route, or concentrationImplantFU time
NumberSizeSiteTypeCoating

Ayan et al. [8]Male rabbits1: control90.1 mg/kg IVTibiaTitanium screwNo4 weeks
2: ZOLSingle dose

Cardemil et al. [9]Female rats1: control (OVX)280.1 mg/kg IVTibiaTitanium screwNo4 weeks
2: ZOLSingle dose

Carvas et al. [10]Male rabbits1: control (GC)60.1 mg/kg IVTibiaTitanium screwNo18 weeks
2: ZOLSingle dose

Chen et al. [11]Female rats1: control (OVX)120.1 mg/kg IVTibiaTitanium rodHA12 weeks
2: ALNSingle dose
3: SR
4: ZOL

Dikicier et al. [12]Female rats1: control (OVX)120.04 mg/kg IVTibiaTitanium screwNo8 weeks
2: ZOL6 doses

Li et al. [13]Female rabbits1: control (OVX)60.1 mg/kg SCTibiaTitanium screwHA8 weeks
2: ZOL3 doses

de Oliveira et al. [14]Male rats1: control30.0075 mg/kg SCTibiaTitaniumNo4 weeks
2: ZOL3 doses

Qi et al. [15]Female rabbits1: control (OVX)80.1 mg/kg SCTibiaTitanium screwHA12 weeks
2: local ZOL4 doses
3: systemic ZOL
4: local and systemic ZOL

Yaman et al. [16]Male rats1: control70.1 mg/kg IVTibiaTitanium screwHA12 weeks
2: ZOL3 doses

Yildiz et al. [17]Female rabbits1: control (OVX)120.1 mg/kg IVTibiaTitanium screwResorbable blast media8 weeks
2: ZOLSingle dose

Blazsek et al. [18]Female rats1: control50.6 mg/kg IPTail vertebraTitanium screwNo6 weeks
2: ZOL3 doses

von Knoch et al. [19]Rabbits1: control120.015 mg/kg IVFemurTitanium cylinderFiber metal mesh12 weeks
2: ZOLSingle dose

Arnoldi et al. [20]Rabbits1: control61 μg/mlFemurTitanium screwNo10 days
2: ZOL

Miettinen et al. [21]Male rats1: control720 μg/mlFemurTitaniumNo4 weeks
2: ZOL

Gao et al. [22]Female rats1: control (OVX)101 mg/mlTibiaTitaniumHA12 weeks
2: ZOL

Stadlinger et al. [23]Female rats1: control (OVX)88.5 μg/implantTibiaTitaniumNo4 weeks
2: ZOL

Ying et al. [24]Female rats1: control (OVX)1030 μg/implantTibiaTitanium cylinderNo12 weeks
2: ZOL

Pyo et al. [25]Female rats1: control (OVX)108 μg/mlTibiaTitanium screwNo8 weeks
2: ZOL80 μg/ml
800 μg/ml

Sörensen et al. [26]Rats1: control1050 μg/implantTibiaCalcium phosphate bone cementNo3 weeks
2: ZOL

Bobyn et al. [27]Dogs1: control50.2 mg/mlFemurTantalumHA1 year
2: ZOL

ZOL: zoledronate; FU: follow-up; GC: glucocorticoid; HA: hydroxyapatite; ALN: alendronate; SR: strontium ranelate; SC: subcutaneous; IP: intraperitoneal.